Cargando…

Regimens to treat multidrug-resistant tuberculosis: past, present and future perspectives

Over the past few decades, treatment of multidrug-resistant (MDR)/extensively drug-resistant (XDR) tuberculosis (TB) has been challenging because of its prolonged duration (up to 20–24 months), toxicity, costs and sub-optimal outcomes. After over 40 years of neglect, two new drugs (bedaquiline and d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pontali, Emanuele, Raviglione, Mario C., Migliori, Giovanni Battista
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Respiratory Society 2019
Materias:	Mini-Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9489134/ https://www.ncbi.nlm.nih.gov/pubmed/31142549 http://dx.doi.org/10.1183/16000617.0035-2019

Ejemplares similares

New anti-tuberculosis drugs and regimens: 2015 update
por: D'Ambrosio, Lia, et al.
Publicado: (2015)

Combined Use of Delamanid and Bedaquiline to Treat Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis: A Systematic Review
por: Migliori, Giovanni Battista, et al.
Publicado: (2017)

Effects of COVID-19 on tuberculosis control: past, present, and future
por: Silva, Denise Rossato, et al.
Publicado: (2022)

Numbers needed to treat to prevent tuberculosis
por: Matteelli, Alberto, et al.
Publicado: (2015)

Hepatitis in Malaysia: Past, Present, and Future
por: Raihan, Ruksana
Publicado: (2016)

Bedaquiline-containing regimens and multidrug-resistant tuberculosis: a systematic review and meta-analysis
por: Hatami, Hossein, et al.
Publicado: (2022)

Delamanid-containing regimens and multidrug-resistant tuberculosis: A systematic review and meta-analysis
por: Nasiri, Mohammad Javad, et al.
Publicado: (2022)

Tuberculosis in the time of COVID-19: quality of life and digital innovation
por: Visca, Dina, et al.
Publicado: (2020)

Past, Present, and Future of Viral Hepatitis in Bangladesh
por: Mamun-Al-Mahtab,
Publicado: (2016)

Viral Hepatitis in Cambodia: Past, Present, and Future
por: Sreng, Bun, et al.
Publicado: (2016)

Viral Hepatitis in Mongolia: Past, Present, and Future
por: Tsatsralt-Od, Bira
Publicado: (2016)

Viral Hepatitis in Nepal: Past, Present, and Future
por: Shrestha, Ananta
Publicado: (2016)

Viral Hepatitis in Korea: Past, Present, and Future
por: Lee, Hyo-Suk
Publicado: (2016)

Viral Hepatitis in Indonesia: Past, Present, and Future
por: Mulyanto,
Publicado: (2016)

Viral Hepatitis in Pakistan: Past, Present, and Future
por: Butt, Amna Subhan, et al.
Publicado: (2016)

Past, Present, and Future of Viral Hepatitis C in Japan
por: Yatsuhashi, Hiroshi
Publicado: (2016)

Pre‐implantation genetic testing: Past, present, future
por: Takeuchi, Kazuhiro
Publicado: (2020)

Carbapenems to Treat Multidrug and Extensively Drug-Resistant Tuberculosis: A Systematic Review
por: Sotgiu, Giovanni, et al.
Publicado: (2016)

Human artificial oocytes from patients’ somatic cells: past, present and future
por: Tesarik, Jan, et al.
Publicado: (2021)

Shortened tuberculosis treatment regimens: what is new?
por: Silva, Denise Rossato, et al.
Publicado: (2020)

Mandatory tuberculosis case notification in high tuberculosis-incidence countries: policy and practice
por: Uplekar, Mukund, et al.
Publicado: (2016)

Recent developments in the diagnosis and management of tuberculosis
por: Sulis, Giorgia, et al.
Publicado: (2016)

New and repurposed drugs to treat multidrug- and extensively drug-resistant tuberculosis
por: Silva, Denise Rossato, et al.
Publicado: (2018)

Tuberculosis control, and the where and why of artificial intelligence
por: Doshi, Riddhi, et al.
Publicado: (2017)

Future perspectives for treating patients with geographic atrophy
por: Loewenstein, Anat, et al.
Publicado: (2022)

Gene Therapy in the Management of Erectile Dysfunction (ED): Past, Present, and Future
por: Melman, Arnold, et al.
Publicado: (2009)

Microbial inoculants: reviewing the past, discussing the present and previewing an outstanding future for the use of beneficial bacteria in agriculture
por: Santos, Mariana Sanches, et al.
Publicado: (2019)

The Past, Present and Future of Tuberculosis
Publicado: (1907)

Extensively Drug-resistant Tuberculosis, Italy and Germany
por: Migliori, Giovanni Battista, et al.
Publicado: (2007)

Improving Quality of Patient Data for Treatment of Multidrug- or Rifampin-Resistant Tuberculosis
por: Campbell, Jonathon R., et al.
Publicado: (2020)

Carbohydrate based meningococcal vaccines: past and present overview
por: Berti, Francesco, et al.
Publicado: (2021)

Multidrug-Resistant Tuberculosis in Child Successfully Treated with 9-Month Drug Regimen
por: Achar, Jay, et al.
Publicado: (2015)

Shorter & cheaper regimen to treat multidrug-resistant tuberculosis: A new hope
por: Prasad, Rajendra, et al.
Publicado: (2017)

Cost-Effectiveness of Antiretroviral Therapy for Multidrug-Resistant HIV: Past, Present, and Future
por: Harris, Marianne, et al.
Publicado: (2012)

Multidrug- and Extensively Drug-Resistant Tuberculosis, Germany
por: Eker, Barbara, et al.
Publicado: (2008)

Future perspectives in pulmonary arterial hypertension
por: Simonneau, Gérald, et al.
Publicado: (2016)

Hib Vaccines: Past, Present, and Future Perspectives
por: Zarei, Adi Essam, et al.
Publicado: (2016)

Perspectives on Spinal Dysraphism : Past, Present, and Future
por: Pang, Dachling
Publicado: (2020)

Patient’s Perspectives of Telepsychiatry: The Past, Present and Future
por: Naik, Shalini S, et al.
Publicado: (2020)

Efficacy, safety, and tolerability of a 24-month treatment regimen including delamanid in a child with extensively drug-resistant tuberculosis: A case report and review of the literature
por: Esposito, Susanna, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_vfl1pio5dh8re2cbqvtof72g4p